283 related articles for article (PubMed ID: 31262782)
1. Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity.
Wang J; Pendurthi UR; Rao LVM
Blood; 2019 Aug; 134(7):645-655. PubMed ID: 31262782
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase.
Wang J; Pendurthi UR; Yi G; Rao LVM
Blood; 2021 Jul; 138(4):344-349. PubMed ID: 34075401
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelin encrypts tissue factor: ATP-induced activation of A-SMase leads to tissue factor decryption and microvesicle shedding.
Wang J; Pendurthi UR; Rao LVM
Blood Adv; 2017 May; 1(13):849-862. PubMed ID: 28758160
[TBL] [Abstract][Full Text] [Related]
4. Alterations to Sphingomyelin Metabolism Affect Hemostasis and Thrombosis.
Wang J; Keshava S; Das K; Kolesnick R; Jiang XC; Pendurthi UR; Rao LVM
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):64-78. PubMed ID: 36412194
[TBL] [Abstract][Full Text] [Related]
5. Analysis of tissue factor expression in various cell model systems: cryptic vs. active.
Kothari H; Pendurthi UR; Rao LV
J Thromb Haemost; 2013 Jul; 11(7):1353-63. PubMed ID: 23621622
[TBL] [Abstract][Full Text] [Related]
6. Role of Cell Surface Lipids and Thiol-Disulphide Exchange Pathways in Regulating the Encryption and Decryption of Tissue Factor.
Ansari SA; Pendurthi UR; Rao LVM
Thromb Haemost; 2019 Jun; 119(6):860-870. PubMed ID: 30861549
[TBL] [Abstract][Full Text] [Related]
7. Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation.
Langer F; Ruf W
Thromb Haemost; 2014 Apr; 111(4):590-7. PubMed ID: 24452853
[TBL] [Abstract][Full Text] [Related]
8. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
9. Thiol pathways in the regulation of tissue factor prothrombotic activity.
Versteeg HH; Ruf W
Curr Opin Hematol; 2011 Sep; 18(5):343-8. PubMed ID: 21778880
[TBL] [Abstract][Full Text] [Related]
10. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.
Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U
Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445
[TBL] [Abstract][Full Text] [Related]
11. In vitro expression and inhibition of procoagulant activity produced by bovine alveolar macrophages and peripheral blood cells.
Rashid J; Weiss DJ; Maheswaran SK; Murtaugh MP
Vet Res Commun; 1996; 20(6):519-31. PubMed ID: 8950833
[TBL] [Abstract][Full Text] [Related]
12. Role of thiol pathways in TF procoagulant regulation.
Ruf W
Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S11-2. PubMed ID: 22401798
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.
Cermak J; Key NS; Bach RR; Balla J; Jacob HS; Vercellotti GM
Blood; 1993 Jul; 82(2):513-20. PubMed ID: 8329706
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure.
Vatsyayan R; Kothari H; Pendurthi UR; Rao LV
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1601-11. PubMed ID: 23640483
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tissue factor procoagulant activity on the surface of feline leukocytes in response to treatment with lipopolysaccharide and heat-inactivated fetal bovine serum.
Stokol T; Daddona JL; Choi B
Am J Vet Res; 2010 Jun; 71(6):623-9. PubMed ID: 20513176
[TBL] [Abstract][Full Text] [Related]
16. Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking.
Rothmeier AS; Marchese P; Langer F; Kamikubo Y; Schaffner F; Cantor J; Ginsberg MH; Ruggeri ZM; Ruf W
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1323-1331. PubMed ID: 28495929
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant canine interleukin-6 and interleukin-8 on tissue factor procoagulant activity in canine peripheral blood mononuclear cells and purified canine monocytes.
Ogasawara S; Daddona JL; Trimpert J; Stokol T
Vet Clin Pathol; 2012 Sep; 41(3):325-35. PubMed ID: 22724392
[TBL] [Abstract][Full Text] [Related]
18. [Effect of platelet on procoagulant activity of monocyte].
Xu J; He X; Xiong S
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):478-80. PubMed ID: 11758230
[TBL] [Abstract][Full Text] [Related]
19. The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy.
Wang GH; Lu J; Ma KL; Zhang Y; Hu ZB; Chen PP; Lu CC; Zhang XL; Liu BC
J Atheroscler Thromb; 2019 Jun; 26(6):538-546. PubMed ID: 30429407
[TBL] [Abstract][Full Text] [Related]
20. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
